EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Assessing short‐term and long‐term security and efficacy of anterior nucleus of the thalamus deep brain stimulation for treating drug‐resistant epilepsy: A systematic review and single‐arm meta‐analysis

Gabriel Verly iD, Leonardo de Barros Oliveira, Thiffany Delfino iD, Sávio Batista, Thiago Lopes, Vitória Carvalho, Billy McBenedict, Matheus Oliveira, Raphael Bertani, Pedro Henrique Martins da Cunha, Wellingson Paiva, Bruno Lima Pessoa

Epilepsia · 2024

DOI: 10.1111/epi.17955 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Epilepsia, 2024. Verfasst von Gabriel Verly und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy, Anterior Thalamic Nuclei. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is a widespread invasive procedure for treating drug‐resistant epilepsy. Nonetheless, there is a persistent debate regarding the short‐term and long‐term efficacy and safety of ANT‐DBS. Thus we conducted a systematic review and meta‐analysis. Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA), we searched PubMed, Cochrane, Embase, and Web of Science for studies treating refractory epilepsy with ANT‐DBS. Short‐term analysis was considered for studies with a mean follow‐up of 3 years or less. The following outcomes were assessed for data extraction: procedure responders and nonresponders, increased seizure frequency, complications, and procedure‐related mortality. Of 650 studies, 25 fit our inclusion criteria, involving 427 patients. Previous surgical treatments have been reported in 214 patients (50.1%) and a median average baseline seizure frequency of 64.9 monthly seizures. In the short‐term analysis, we observed a proportion of 67% (95% confidence interval [CI] 54%–79%) of responders and 33% (95% CI 21%–46%) of nonresponders. In addition, 4% (95% CI 0%–9%) of the patients presented increased seizure frequency. In the long‐term analysis, we observed 72% (95% CI 66%–78%) responders and 27% (95% CI 21%–34%) nonresponders. Moreover, there was a 2% (95% CI 0%–5%) increase in seizure frequency. No procedure‐related mortality was reported at any follow‐up. ANT‐DBS effectively treats refractory epilepsy, with lasting short‐term and long‐term benefits. It remains safe and efficient despite complications, showing no procedure‐linked fatalities, high patient responsiveness, and minimal increased seizures. Consistent results over time and low morbidity/mortality rates emphasize its worth. Further research is necessary to diminish the discrepancy among results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDrug Resistant EpilepsyAnterior Thalamic NucleiHumansTreatment Outcome

Stichwörter der Autor:innen

ANTDBSmeta‐analysisneurosurgeryrefractory epilepsy

Autor:innen und Institutionen

  • Faculty of Medicine, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil.
  • Faculty of Medicine, Universidade Estadual de Ponta Grossa (UEPG), Ponta Grossa, Paraná, Brazil.
  • Faculty of Medicine, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro, Brazil.
  • Division of Neurological Surgery, Hospital das Clínicas, Universidade de São Paulo (USP), São Paulo, Brazil.
  • Neurology Department, Hospital das Clínicas, Universidade de São Paulo (USP), São Paulo, Brazil.
  • Division of Neurological Surgery, Hospital Antônio Pedro, Universidade Federal Fluminense (UFF), Niterói, Rio de Janeiro, Brazil.

ORCID-Profile: Gabriel Verly, Thiffany Delfino

Zitieren

APA

Verly, G., Oliveira, L. B., Delfino, T., Batista, S., Lopes, T., Carvalho, V., McBenedict, B., Oliveira, M., Bertani, R., Martins da Cunha, P. H., Paiva, W., & Lima Pessoa, B. (2024). Assessing short‐term and long‐term security and efficacy of anterior nucleus of the thalamus deep brain stimulation for treating drug‐resistant epilepsy: A systematic review and single‐arm meta‐analysis. Epilepsia. https://doi.org/10.1111/epi.17955

Vancouver

Verly G, Oliveira LB, Delfino T, Batista S, Lopes T, Carvalho V, et al. Assessing short‐term and long‐term security and efficacy of anterior nucleus of the thalamus deep brain stimulation for treating drug‐resistant epilepsy: A systematic review and single‐arm meta‐analysis. Epilepsia. 2024. doi:10.1111/epi.17955

BibTeX
@article{Verly2024,
  author = {Verly, Gabriel and Oliveira, Leonardo de Barros and Delfino, Thiffany and Batista, Sávio and Lopes, Thiago and Carvalho, Vitória and McBenedict, Billy and Oliveira, Matheus and Bertani, Raphael and Martins da Cunha, Pedro Henrique and Paiva, Wellingson and Lima Pessoa, Bruno},
  title = {Assessing short‐term and long‐term security and efficacy of anterior nucleus of the thalamus deep brain stimulation for treating drug‐resistant epilepsy: A systematic review and single‐arm meta‐analysis},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17955}
}
Kostenlos starten →